SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GMED - GenoMed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: jmhollen who wrote (143)7/14/2004 10:22:20 AM
From: Tadsamillionaire  Respond to of 347
 
The more income the better. It looks to me that GMED could start an income stream through licensing hospitals and getting a per individual fee for treatment using their process. Pretty easy money on their part if so,,,,



To: jmhollen who wrote (143)7/14/2004 10:23:12 AM
From: Henry Niman  Read Replies (1) | Respond to of 347
 
The problem with avian flu is recombination (http://www.recombinomics.com ) and if this issue is not addressed, the problem will continue to spiral higher.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News